FOOD AND DRUG ADMINISTRATION

First Page		Document Content
Ketones Alcohol abuse Pharmacology Morphinans Naltrexone Center for Drug Evaluation and Research Opioid dependence Alkermes Methadone Chemistry Food and Drug Administration Organic chemistry		FOOD AND DRUG ADMINISTRATION Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 82,05 KB Share Document on Facebook

	Key Techniques to Reduce Severe Injection Site Reactions ® VIVITROL (naltrexone for extended-release injectable suspension) Intramuscular Injection • Use appropriate VIVITROL needle to ensure the injection reaches the DocID: 1uZFA - View Document
	MEDICATION GUIDE VIVITROL® (viv-i-trol) (naltrexone for extended-release injectable suspension) Read this Medication Guide before you start receiving VIVITROL injections and each time you receive an injection. There may DocID: 1udj5 - View Document
	Contrave Contrave is a new medication which has been approved by the FDA for weight loss. It is a combination of naltrexone (Vivitrol, Revia) and bupropion (Wellbutrin). It contains a black box warning for suicidal thoug DocID: 1u1gu - View Document
	ATION ASSISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MEDICATION ASSISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MED SISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MEDICATION ASSISTED TREATMENT• BUPRENOR DocID: 1tG05 - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CONTRAVE® safely and effectively. See full prescribing information for CONTRAVE. CONTRAVE (naltrexone HCl and bupro DocID: 1sTJs - View Document